Kolesnik, O. P., & Kuzmenko, V. O. (2020). ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer. Pathologia, (1). https://doi.org/10.14739/2310-1237.2020.1.203639